Most Recent
Aboriginal art supplier misled consumers with Indonesian-made fakes, judge finds
A judge has found an Aboriginal art and souvenir supplier misled consumers by creating the false impression its products were made in Australia by Indigenous people, when they were actually made in Indonesia, the consumer watchdog said Wednesday.
AMS loses bid to restrict group size in pelvic mesh class action
The judge overseeing a class action against American Medical Systems over allegedly defective pelvic mesh implants has rejected the medical device maker's bid to alter the start date for a sub-group of class members.
Heinz drops appeal in sugary kids snacks case
H.J. Heinz Company has dropped its appeal of a ruling that it marketed its sugary snacks to kids as healthy, after the ACCC won a fraction of the $10 million fine it sought for the consumer law violations.
ACCC to act as intervenor in Nature’s Care case over Australian Made logo
The Australian Competition and Consumer Commission has successfully escaped a lawsuit by a Chinese vitamin company Nature's Care after arguing it had been wrongly "dragged" into the case.
Bannister Law off Ford class action in wake of funder feud
Bannister Law has withdrawn from a class action it filed against Ford over allegedly defective Powershift transmissions following a dispute between the firm and the litigation funder that's backing the case.
Cash Converters to pay $16.4M to settle consumer class action
Cash Converters has reached a settlement on the eve of trial in one of two consumer class actions alleging it engaged in unconscionable conduct by imposing high interest rates on short-term loans.
ASIC defeats referee bid in AMP insurance case
ASIC has successfully opposed a Federal Court judge's push to appoint an independent referee in its case against AMP Financial Planning over alleged insurance churning.
ACCC’s loss in Pfizer misuse of market power case to stand
The High Court has dismissed the ACCC's bid to appeal a Full Federal Court decision upholding a ruling that drug giant Pfizer did not misuse its market power in the months leading up to the expiration of the patent for its blockbuster cholesterol drug Lipitor.
High Court won’t hear Yazaki appeal of $46M fine
Japanese car parts manufacturer Yazaki will have to pay a $46 million penalty for price-fixing, now that the High Court has refused to hear its appeal of the record competition fine.
ACCC sets new bar for competition penalties
The ACCC secured $120.1 million in competition penalties in the 2017-18 financial year, including a record $46 million fine, and with a strong influx of immunity applications throughout the year, the cartel cop shows no signs of slowing down.